Skip to main content

Advertisement

Log in

Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine

  • Brief Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract 

We report an 11-year-old boy with hypertension and chronic intestinal pseudo-obstruction, which renders him totally dependent on parenteral nutrition and prevents the use of oral medications. Here we report the feasibility of utilizing chronic IV enalaprilat and transdermal clonidine on a chronic basis to control hypertension. Over the last 10 months, the patient’s hypertension has been well controlled by 1.25 mg IV enalaprilat every 8 h and a 0.2-mg clonidine patch every 6 days, with no apparent side-effects. There are no reports of IV enalaprilat usage exceeding 3 weeks’ duration. Therefore we believe that it is possible to effect reasonable management of chronic hypertension with the use of chronic IV enalaprilat and transdermal clonidine therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 26 April 2000 / Revised: 7 August 2000 / Accepted: 11 August 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zawaideh, M., Duncan, B., Joseph, M. et al. Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine. Pediatr Nephrol 16, 85–86 (2001). https://doi.org/10.1007/s004670000483

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004670000483

Navigation